International Reviews of Immunology

Papers
(The TQCC of International Reviews of Immunology is 9. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-08-01 to 2025-08-01.)
ArticleCitations
Combining the past and present to advance immuno-radiotherapy of cancer57
Regulatory Effects of Clock and Bmal1 on Circadian Rhythmic TLR Expression52
Transforming growth factor-β in tumor microenvironment: Understanding its impact on monocytes and macrophages for its targeting41
Chemokines: A key driver for inflammation in protozoan infection32
Breaking the graft-versus-host-disease barrier: Mesenchymal stromal/stem cells as precision healers24
Immunological and biological dissection of normal and tumoral salivary glands22
The molecular landscape of T cell exhaustion in the tumor microenvironment and reinvigoration strategies21
Exploring the role of neutrophils in infectious and noninfectious pulmonary disorders20
B cell antigens: A key to optimizing CAR-T cell therapy19
CAR-T cells for cancer immunotherapy—the barriers ahead and the paths through19
An insight into COVID-19 host immunity at single-cell resolution18
Epigenetic regulation of T cell development18
Th17 cells: A new target in kidney disease research17
Molecular mechanisms of ferroptosis and their role in inflammation16
Role of thymus in health and disease15
Immunological processes of enhancers and suppressors of long non-coding RNAs associated with brain tumors and inflammation14
The NLRP3 inflammasome: Mechanisms of activation, regulation, and role in diseases14
Research progress on the role and mechanism of action of exosomes in autoimmune thyroid disease13
Host factors subverted by Mycobacterium tuberculosis: Potential targets for host directed therapy13
Retraction13
Gut microbiome as a treatment in colorectal cancer10
Next generation strategies to recover immunological tolerance in celiac disease9
B7-H3-targeted CAR-T cell therapy for solid tumors9
The role of TRIM59 in immunity and immune-related diseases9
Dimensions of inflammation in host defense and diseases9
FUNDC1 mediated mitochondria-dependent ferroptosis of epithelial cells in model of asthma by FBXL2/ar/GPX4 signaling pathway of SUMO1 at K1369
0.028657197952271